NCT05508841View on ClinicalTrials.gov

Understanding How Alzheimer's Disease Impacts the Therapeutic Response to Transcranial Direct Current Stimulation

NARecruitingINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Alzheimer Disease
Interventions
OTHER

tDCS and Cognitive Training

Participants will receive mild stimulation or no stimulation along with cognitive training

Trial Locations (1)

M6A 2E1

RECRUITING

Baycrest Health Sciences, Toronto

All Listed Sponsors
collaborator

BrightFocus Foundation

OTHER

lead

Baycrest

OTHER